Contact

Kanza Home About Services What the Evidence Says Safety & Screening Trials & Access Contact A careful guide to an early, high-risk topic Ibogaine For Alcohol A plainspoken look at what is known, what is uncertain, and why screening, monitoring, and continuing support matter when people ask about ibogaine and alcohol addiction. Kanza is an independent resource on ibogaine, alcohol use, and emerging evidence. It is not a clinic or a treatment recommendation. Examine the evidence 01 Interest is real. Certainty is not. Any discussion of this drug has to begin with safety. The short version Ibogaine is a psychoactive compound with early research signals, serious cardiovascular concerns, and no established role as a standard treatment for alcohol use disorder. People exploring ibogaine treatment often want relief from alcohol cravings and withdrawal symptoms. That hope should sit alongside the limits of current clinical research: small studies, incomplete follow-up, and no randomized controlled trials comparing ibogaine with placebo or established care. The registered alcoholism study design illustrates how cautiously this question has been approached, with inpatient dosing and planned follow-up over time. Evidence about alcohol use disorder remains preliminary, not proof of a cure. Origins and mechanism What is ibogaine? Ibogaine is a psychoactive indole alkaloid derived from the iboga root, a shrub associated with Gabon and parts of Central Africa. It is distinct from conventional medications used in addiction treatment because its acute psychological effects can be prolonged and intense. The compound is commonly discussed within psychedelic therapy, yet it affects more than perception. Ibogaine and its metabolite noribogaine are believed to interact with multiple receptors and systems in the central nervous system. Its complex pharmacology is one reason simple claims about a “reset” should be treated carefully. A useful starting point is the overview of ibogain

Contact

A clear route, when it is available.